Form 4: Elutia Inc. Executive Michelle LeRoux Williams Reports Stock Transactions

Michelle LeRoux Williams, Chief Scientific Officer of Elutia Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• On March 10, 2025, Michelle LeRoux Williams, Chief Scientific Officer of Elutia Inc., reported transactions involving Class A Common Stock.
• 12,500 shares were acquired through the vesting of restricted stock units.
• 4,613 shares were withheld by the issuer to satisfy tax obligations related to the vesting.
• Following these transactions, Williams directly owns 76,286 shares of Class A Common Stock.
• Williams also holds 87,500 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units as a way to align management's interests with those of shareholders.
• Vesting schedules and tax withholding practices are standard components of equity compensation plans.
• Similar filings are regularly made by executives at comparable companies in the biotechnology and medical device sectors, such as Medtronic, Boston Scientific, and Stryker, when they receive or dispose of company stock.

Stakeholder Impact

• The vesting of restricted stock units can have a minor dilutive effect on existing shareholders.
• The transactions reflect the ongoing compensation and incentives for the Chief Scientific Officer.

Key Dates